+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Irbesartan"

Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • March 2025
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 109 Pages
  • China
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Irbesartan is a medication used to treat high blood pressure and heart failure. It belongs to a class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which causes blood vessels to narrow and increases blood pressure. Irbesartan is also used to reduce the risk of stroke in people with high blood pressure and left ventricular hypertrophy, a condition in which the heart's left ventricle is enlarged. Irbesartan is available as a generic drug and is marketed under several brand names, including Avapro, Karvea, and Aprovel. It is available in tablet form and is usually taken once or twice daily. In the Irbesartan market, some of the companies include Sanofi, Bristol-Myers Squibb, Daiichi Sankyo, and Teva Pharmaceuticals. Show Less Read more